Eli Halimah

663 total citations
61 papers, 453 citations indexed

About

Eli Halimah is a scholar working on General Health Professions, Plant Science and Molecular Biology. According to data from OpenAlex, Eli Halimah has authored 61 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in General Health Professions, 15 papers in Plant Science and 12 papers in Molecular Biology. Recurrent topics in Eli Halimah's work include Healthcare Quality and Satisfaction (9 papers), Antibiotic Use and Resistance (9 papers) and Medicinal Plant Research (8 papers). Eli Halimah is often cited by papers focused on Healthcare Quality and Satisfaction (9 papers), Antibiotic Use and Resistance (9 papers) and Medicinal Plant Research (8 papers). Eli Halimah collaborates with scholars based in Indonesia, Japan and Netherlands. Eli Halimah's co-authors include Rizky Abdulah, Ajeng Diantini, Keri Lestari, Ivan Surya Pradipta, Hiroshi Koyama, Yasmiwar Susilawati, Anas Subarnas, Ida Parwati, Euis Julaeha and Tri Hanggono Achmad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Frontiers in Pharmacology.

In The Last Decade

Eli Halimah

51 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Halimah Indonesia 10 118 98 46 43 43 61 453
Keri Lestari Indonesia 13 180 1.5× 70 0.7× 83 1.8× 62 1.4× 35 0.8× 71 679
Jean-Baptiste Nikiéma Burkina Faso 12 107 0.9× 165 1.7× 75 1.6× 32 0.7× 61 1.4× 22 607
Hui Poh Goh Brunei 14 133 1.1× 74 0.8× 52 1.1× 92 2.1× 45 1.0× 34 659
Dilip Chandrasekhar India 12 60 0.5× 122 1.2× 32 0.7× 18 0.4× 45 1.0× 52 566
Melisa Intan Barliana Indonesia 15 132 1.1× 67 0.7× 50 1.1× 38 0.9× 20 0.5× 95 559
Siraj Uddin Bangladesh 12 56 0.5× 145 1.5× 37 0.8× 24 0.6× 57 1.3× 30 459
Nebojša Stilinović Serbia 15 139 1.2× 95 1.0× 29 0.6× 19 0.4× 63 1.5× 52 623
Promise Madu Emeka Saudi Arabia 15 87 0.7× 95 1.0× 38 0.8× 21 0.5× 85 2.0× 65 573
Sri Adi Sumiwi Indonesia 10 76 0.6× 105 1.1× 51 1.1× 28 0.7× 39 0.9× 81 387
Aduragbenro Adedapo Nigeria 11 58 0.5× 104 1.1× 24 0.5× 27 0.6× 80 1.9× 52 526

Countries citing papers authored by Eli Halimah

Since Specialization
Citations

This map shows the geographic impact of Eli Halimah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Halimah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Halimah more than expected).

Fields of papers citing papers by Eli Halimah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Halimah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Halimah. The network helps show where Eli Halimah may publish in the future.

Co-authorship network of co-authors of Eli Halimah

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Halimah. A scholar is included among the top collaborators of Eli Halimah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Halimah. Eli Halimah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halimah, Eli, et al.. (2025). Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC Patients. Cancer Management and Research. Volume 17. 383–395. 3 indexed citations
2.
Halimah, Eli, et al.. (2024). The cytotoxic and apoptotic activity of Costus speciosus (Koenig) Smith (Costaceae) leaves against MCF-7 and HeLa cells. Journal of Herbmed Pharmacology. 13(3). 491–500. 1 indexed citations
3.
Puspitasari, Irma Melyani, et al.. (2024). Simultaneous use of Morinda citrifolia fruit extract and amlodipine: Antihypertensive activity and sub-chronic toxicity in rats. Journal of Applied Pharmaceutical Science.
4.
5.
Halimah, Eli, et al.. (2023). Implementasi Rasionalitas Penggunaan Antibiotik pada Beberapa Rumah Sakit di Indonesia: Kajian Literatur Mengenai Kualitas dan Tantangannya. Jurnal Sains Farmasi & Klinis. 9(3). 227–227. 1 indexed citations
6.
Halimah, Eli, et al.. (2023). Screening of Costus speciosus and Determination of Antioxidant Potential Using DPPH Method: A Review. European Journal of Medicinal Plants. 34(7). 17–28. 2 indexed citations
7.
Ruslin, Ruslin, et al.. (2023). Antibacterial Potency of an Active Compound from Sansevieria trifasciata Prain: An Integrated In Vitro and In Silico Study. Molecules. 28(16). 6096–6096. 3 indexed citations
8.
Halimah, Eli, et al.. (2022). Analisis Efektivitas Biaya Pasien PROLANIS DM Tipe 2 di Puskesmas Kota Bandung. Jurnal Sains dan Kesehatan. 4(1). 19–27. 1 indexed citations
9.
Alfian, Sofa D., et al.. (2021). Lack of Awareness of the Impact of Improperly Disposed Of Medications and Associated Factors: A Cross-Sectional Survey in Indonesian Households. Frontiers in Pharmacology. 12. 630434–630434. 18 indexed citations
10.
Hadisaputri, Yuni Elsa, Eli Halimah, Mutakin Mutakin, et al.. (2021). Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells. Breast Cancer Targets and Therapy. Volume 13. 447–457. 37 indexed citations
11.
12.
Halimah, Eli, et al.. (2020). Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Sinuraya, ‎Rano K., et al.. (2018). Effectiveness of Ampicillin and Ampicillin-Gentamicin for Children under Five Years Old with Pneumonia. Indonesian Journal of Clinical Pharmacy. 7(1). 52–58.
14.
Halimah, Eli, et al.. (2018). Pharmaceutical Counseling Has a Positive Impact on Quality of Life of Hypertension Patients. SHILAP Revista de lepidopterología. 3(1). 2 indexed citations
15.
Sinuraya, ‎Rano K., et al.. (2017). Economic Evaluation of the Use of Cefotaxime and Ceftazidime in the Treatment of Pneumonia in Pediatric Patients. SHILAP Revista de lepidopterología. 2(1). 2 indexed citations
16.
Halimah, Eli, et al.. (2016). N-MID Osteocalcin (N-MID Oc) and β-Crosslaps (β-CTx) as Biochemical Markers of Bone Turnover in Menopausal Women. SHILAP Revista de lepidopterología. 5(1). 67–74.
17.
Abdulah, Rizky, Melisa Intan Barliana, Ivan Surya Pradipta, et al.. (2014). Assessment of patient care indicators at community pharmacies in Bandung City, Indonesia.. PubMed. 45(5). 1196–201. 13 indexed citations
18.
Halimah, Eli, Ajeng Diantini, Ivan Surya Pradipta, et al.. (2014). Induction of caspase cascade pathway by kaempferol-3-O-rhamnoside in LNCaP prostate cancer cell lines. Biomedical Reports. 3(1). 115–117. 35 indexed citations
19.
Pradipta, Ivan Surya, Ida Parwati, Keri Lestari, et al.. (2013). Antibiotic resistance in sepsis patients: Evaluation and recommendation of antibiotic use. North American Journal of Medical Sciences. 5(6). 344–344. 62 indexed citations
20.
Diantini, Ajeng, Anas Subarnas, Keri Lestari, et al.. (2012). Kaempferol-3-O-rhamnoside isolated from the leaves of Schima wallichii Korth. inhibits MCF-7 breast cancer cell proliferation through activation of the caspase cascade pathway. Oncology Letters. 3(5). 1069–1072. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keri Lestari Breakdown of academic impact, for papers by Jean-Baptiste Nikiéma Breakdown of academic impact, for papers by Hui Poh Goh Breakdown of academic impact, for papers by Dilip Chandrasekhar Breakdown of academic impact, for papers by Melisa Intan Barliana Breakdown of academic impact, for papers by Siraj Uddin Breakdown of academic impact, for papers by Nebojša Stilinović Breakdown of academic impact, for papers by Promise Madu Emeka Breakdown of academic impact, for papers by Sri Adi Sumiwi Breakdown of academic impact, for papers by Aduragbenro Adedapo
Rankless by CCL
2026